Blepharoptosis, also known as ptosis, is a medical condition characterized by the drooping or sagging of the upper eyelid. The term is derived from the Greek words "blepharon," meaning eyelid, and "ptosis," which translates to falling.
In normal circumstances, the levator muscle, responsible for lifting and maintaining the position of the upper eyelid, functions effectively. However, in cases of blepharoptosis, this muscle weakens, stretches, or becomes damaged, leading to the eyelid appearing lower than usual. This condition can affect one or both eyes, and the severity of the drooping can vary widely among individuals.
Blepharoptosis can either be present at birth (congenital ptosis) or develop later in life (acquired ptosis). Congenital ptosis often occurs due to the abnormal development of the levator muscle or other structures supporting the eyelid. Acquired ptosis, on the other hand, can result from age-related muscle or tissue degeneration, trauma, nerve damage, muscular disorders, or underlying systemic diseases.
Symptoms of blepharoptosis may include a visibly drooping upper eyelid, reduced or obstructed vision, strained forehead muscles from compensatory lifting, and difficulties in fully opening the affected eye(s). Depending on the severity and underlying cause, treatment options for blepharoptosis can range from observation and lifestyle modifications to surgical intervention. Surgical procedures involve tightening or repositioning the levator muscle, or attaching an artificial support material to aid in eyelid elevation.
Prompt diagnosis and management of blepharoptosis are crucial to prevent potential vision problems, especially if it affects the line of sight. An ophthalmologist or an oculoplastic surgeon is
